Arentor DC 250 mg Intramammary Suspension for Dry Cows
Arentor DC 250 mg Intramammary Suspension for Dry Cows
Authorised
- Cefalonium dihydrate
Product identification
Medicine name:
Arentor DC 250 mg Intramammary Suspension for Dry Cows
Arentor DC 250 mg sospensione intramammaria per bovine in asciutta
Active substance:
- Cefalonium dihydrate
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cefalonium dihydrate269.63milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
- Cattle
-
Meat and offal21day
-
Milk96hour96 hours after calving if the dry period is longer than 54 days
-
Milk58day58 days following the treatment if the dry period is less than or equal to 54 days
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51DB90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Italy
Package description:
- A 3g coloured low density polyethylene intramammary syringe with a coloured low density polyethylene dual capPack sizes:Buckets of 120 intramammary syringes and 120 individually wrapped cleaning towelscontaining isopropyl alcohol.
- A 3g coloured low density polyethylene intramammary syringe with a coloured low density polyethylene dual capPack sizes:Cartons of 20 intramammary syringes and 20 individually wrapped cleaning towels containing isopropyl alcohol.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Univet Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Univet Limited
Responsible authority:
- Ministry Of Health
Authorisation number:
- 105182
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0389/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Estonia
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Italian (PDF)
Published on: 5/06/2024
Updated on: 4/06/2024
How useful was this page?: